| PATHLAB TAKE OVER BY DOREVITCH PATHOLOGY |
|
|
|
We have been contacted by PathLab members concerned about their entitlements when PathLab is taken over by Symbion Health Ltd/Dorevitch Pathology. We understand that the date of transmission of business is 1 March 2010. Members have advised the MSAV that they have received letters of offer from Dorevitch at rates of pay which are significantly below the mandated rates of pay in the Dorevitch EBA. In addition, no position descriptions have been provided by Dorevitch to the scientists concerned. We advise members employed at PathLab not to sign any offers of employment with Dorevitch Pathology until these matters are resolved. It is our view that it is not legally possible to contract out of the terms and conditions and rates of pay of the Dorevitch EBA. There will be a meeting of PathLab scientists at 3.30 pm on Monday 22 February at the Burwood laboratory to discuss transmission of business issues. Members with individual concerns should contact Terry O’Loughlin at our offices.
|




MSAV + VPA +AHP News



s.jpg)







